Clinical Trial Update: Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII) [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating whether a PCSK9 inhibitor can reduce the inflammatory response and organ dysfunction after coronary arte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Myocardial Ischemia

Drugs mentioned

• PCSK9 inhibitor (PCSK9 inhibitor)

Snippet

Sponsor: Nanjing Medical University | Conditions: Myocardial Ischaemic Syndrome, Coronary Heart Disease | NA | Status: NOT_YET_RECRUITING